Literature DB >> 24249707

Sixty-five years since the New York heat wave: advances in sweat testing for cystic fibrosis.

Jake T B Collie1, R John Massie, Oliver A H Jones, Vicky A LeGrys, Ronda F Greaves.   

Abstract

The sweat test remains important as a diagnostic test for cystic fibrosis (CF) and has contributed greatly to our understanding of CF as a disease of epithelial electrolyte transport. The standardization of the sweat test, by Gibson and Cooke [Gibson and Cooke (1959) Pediatrics 1959;23:5], followed observations of excessive dehydration amongst patients with CF and confirmed the utility as a diagnostic test. Quantitative pilocarpine iontophoresis remains the gold standard for sweat induction, but there are a number of collection and analytical methods. The pathophysiology of electrolyte transport in sweat was described by Quinton [Quinton (1983) Nature 1983;301:421-422], and this complemented the developments in genetics that discovered the cystic fibrosis transmembrane conductance regulator (CFTR), an epithelial-based electrolyte transport protein. Knowledge of CF has since increased rapidly and further developments in sweat testing include: new collection methods, further standardization of the technique with international recommendations and age related reference intervals. More recently, sweat chloride values have been used as proof of effect for the new drugs that activate CFTR. However, there remain issues with adherence to sweat test guidelines in many countries and there are gaps in our knowledge, including reference intervals for some age groups and stability of sweat samples in transport. Furthermore, modern methods of elemental quantification need to be explored as alternatives to the original analytical methods for sweat electrolyte measurement. The purpose of this review is therefore to describe the development of the sweat test and consider future directions.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CFTR activation; best practice guidelines; cystic fibrosis; standardization; sweat chloride methods; sweat test

Mesh:

Substances:

Year:  2013        PMID: 24249707     DOI: 10.1002/ppul.22945

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  22 in total

1.  Australasian Guideline (2nd Edition): an Annex to the CLSI and UK Guidelines for the Performance of the Sweat Test for the Diagnosis of Cystic Fibrosis.

Authors:  John Massie; Ronda Greaves; Michael Metz; Veronica Wiley; Peter Graham; Samantha Shepherd; Richard Mackay
Journal:  Clin Biochem Rev       Date:  2017-11

2.  Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.

Authors:  Steven M Rowe; Sonya L Heltshe; Tanja Gonska; Scott H Donaldson; Drucy Borowitz; Daniel Gelfond; Scott D Sagel; Umer Khan; Nicole Mayer-Hamblett; Jill M Van Dalfsen; Elizabeth Joseloff; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2014-07-15       Impact factor: 21.405

Review 3.  Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments.

Authors:  William B Guggino; Liudmila Cebotaru
Journal:  Expert Opin Biol Ther       Date:  2017-07-06       Impact factor: 4.388

Review 4.  Working Up a Good Sweat - The Challenges of Standardising Sweat Collection for Metabolomics Analysis.

Authors:  Joy N Hussain; Nitin Mantri; Marc M Cohen
Journal:  Clin Biochem Rev       Date:  2017-02

5.  Sources of Variation in Sweat Chloride Measurements in Cystic Fibrosis.

Authors:  Joseph M Collaco; Scott M Blackman; Karen S Raraigh; Harriet Corvol; Johanna M Rommens; Rhonda G Pace; Pierre-Yves Boelle; John McGready; Patrick R Sosnay; Lisa J Strug; Michael R Knowles; Garry R Cutting
Journal:  Am J Respir Crit Care Med       Date:  2016-12-01       Impact factor: 21.405

6.  The use of ivacaftor in CFTR mutations resulting in residual functioning protein.

Authors:  S Guigui; J Wang; R I Cohen
Journal:  Respir Med Case Rep       Date:  2016-10-18

7.  Thirty Years of Sweat Chloride Testing at One Referral Center.

Authors:  Alethéa Guimarães Faria; Fernando Augusto Lima Marson; Carla Cristina Souza Gomez; Maria de Fátima Servidoni; Antônio Fernando Ribeiro; José Dirceu Ribeiro
Journal:  Front Pediatr       Date:  2017-10-26       Impact factor: 3.418

8.  Sweat test and cystic fibrosis: overview of test performance at public and private centers in the state of São Paulo, Brazil.

Authors:  Maria Fátima Servidoni; Carla Cristina Souza Gomez; Fernando Augusto Lima Marson; Adyléia Aparecida Dalbo Contrera Toro; Maria Ângela Gonçalves de Oliveira Ribeiro; José Dirceu Ribeiro; Antônio Fernando Ribeiro
Journal:  J Bras Pneumol       Date:  2017 Mar-Apr       Impact factor: 2.624

9.  Pulsed direct and constant direct currents in the pilocarpine iontophoresis sweat chloride test.

Authors:  Carla Cristina Souza Gomez; Maria de Fatima Servidoni; Fernando Augusto de Lima Marson; Paulo Jose Coelho Canavezi; Adriana Mendes Vinagre; Eduardo Tavares Costa; Antonio Fernando Ribeiro; Maria Angela Gonçalves de Oliveira Ribeiro; Adyleia Aparecida Dalbo Contrera Toro; Celia Regina Pavan; Michelle Vivine Sá Dos Santos Rondon; Sonia Leticia Silva Lorena; Francisco Ubaldi Vieria; Jose Dirceu Ribeiro
Journal:  BMC Pulm Med       Date:  2014-12-13       Impact factor: 3.317

10.  Skin Biomarkers for Cystic Fibrosis: A Potential Non-Invasive Approach for Patient Screening.

Authors:  Cibele Zanardi Esteves; Letícia de Aguiar Dias; Estela de Oliveira Lima; Diogo Noin de Oliveira; Carlos Fernando Odir Rodrigues Melo; Jeany Delafiori; Carla Cristina Souza Gomez; José Dirceu Ribeiro; Antônio Fernando Ribeiro; Carlos Emílio Levy; Rodrigo Ramos Catharino
Journal:  Front Pediatr       Date:  2018-01-10       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.